Revolution Medicines, Inc. - RVMD

Latest data: 10/28/2026 10:01:44 PM
EDGAR CIK 0001628171

Buy Breakdown

Total $0

Sell Breakdown

Total $16,650,198

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
09/25/2026
10b5-1
09/29/2026
SVP & General Counsel
Officer
Sell
-765 @ $207.32
($158,599.88)
51,776 (-1.46%) Direct
09/18/2026
10b5-1
09/22/2026
Chief Global Commercialization Officer
Officer
Sell
-1,764 @ $196.94
($347,402.16)
40,352 (-4.19%) Direct
09/16/2026
10b5-1
09/18/2026
Chief Financial Officer
CFO
Sell
-4,053 @ $199.24
($807,513.37)
119,216 (-3.29%) Direct
09/16/2026
10b5-1
09/18/2026
SVP & General Counsel
Officer
Sell
-3,366 @ $199.24
($670,631.26)
52,541 (-6.02%) Direct
09/16/2026
10b5-1
09/18/2026
President and Chief Executive Officer
CEO Director
Sell
-13,988 @ $199.24
($2,786,938.39)
253,342 (-5.23%) Direct
09/16/2026
10b5-1
09/18/2026
Chief Operating Officer
Officer
Sell
-4,967 @ $199.24
($989,612.58)
149,680 (-3.21%) Direct
09/16/2026
10b5-1
09/18/2026
Senior Advisor to the Chief Executive Officer
CEO
Sell
-5,569 @ $199.24
($1,109,554.38)
286,307 (-1.91%) Direct
09/16/2026
10b5-1
09/18/2026
Chief Global Commercialization Officer
Officer
Sell
-1,774 @ $199.24
($353,449.10)
42,116 (-4.04%) Direct
09/16/2026
10b5-1
09/18/2026
Chief Development Officer
Officer
Sell
-341 @ $199.24
($67,940.67)
52,868 (-0.64%) Direct
06/16/2026
10b5-1
06/18/2026
Chief Financial Officer
CFO
Sell
-2,722 @ $156.12
($424,956.46)
123,269 (-2.16%) Direct
06/16/2026
10b5-1
06/18/2026
General Counsel
Officer
Sell
-2,157 @ $156.12
($336,748.90)
56,521 (-3.68%) Direct
06/16/2026
10b5-1
06/18/2026
President and Chief Executive Officer
CEO Director
Sell
-10,020 @ $156.12
($1,564,310.38)
267,330 (-3.61%) Direct
06/16/2026
10b5-1
06/18/2026
President, Research and Development
Officer
Sell
-4,175 @ $156.12
($651,797.66)
291,876 (-1.41%) Direct
06/16/2026
06/18/2026
Chief Global Commercialization Officer
Officer
Sell
-4,615 @ $156.12
($720,490.11)
49,975 (-8.45%) Direct
03/19/2026
10b5-1
03/19/2026
General Counsel
Officer
Sell
-1,163 @ $97.44
($113,322.72)
58,518 (-1.95%) Direct
03/17/2026
10b5-1
03/19/2026
Chief Financial Officer
CFO
Sell
-2,753 @ $99.48
($273,869.54)
125,512 (-2.15%) Direct
03/17/2026
10b5-1
03/19/2026
General Counsel
Officer
Sell
-1,795 @ $99.48
($178,567.32)
59,681 (-2.92%) Direct
03/17/2026
10b5-1
03/19/2026
President and Chief Executive Officer
CEO Director
Sell
-12,871 @ $99.48
($1,280,412.23)
276,698 (-4.44%) Direct
03/17/2026
10b5-1
03/19/2026
Chief Operating Officer
Officer
Sell
-4,583 @ $99.48
($455,918.67)
157,570 (-2.83%) Direct
03/17/2026
10b5-1
03/19/2026
President, Research and Development
Officer
Sell
-4,302 @ $99.48
($427,964.68)
295,398 (-1.44%) Direct
03/17/2026
10b5-1
03/19/2026
EVP, Clinical Development
Officer
Sell
-2,010 @ $99.48
($199,955.60)
116,063 (-1.70%) Direct
03/17/2026
10b5-1
03/19/2026
Chief Medical Officer
Officer
Sell
-2,073 @ $99.48
($206,222.87)
101,366 (-2.00%) Direct
01/21/2026
10b5-1
01/23/2026
General Counsel
Officer
Sell
-908 @ $115.60
($104,964.80)
46,976 (-1.90%) Direct
12/16/2025
10b5-1
12/18/2025
Chief Financial Officer
CFO
Sell
-3,104 @ $77.09
($239,288.60)
108,065 (-2.79%) Direct
12/16/2025
10b5-1
12/18/2025
General Counsel
Officer
Sell
-2,688 @ $76.82
($206,483.83)
47,884 (-5.32%) Direct
12/16/2025
10b5-1
12/18/2025
President and Chief Executive Officer
CEO Director
Sell
-15,394 @ $76.82
($1,182,525.52)
232,469 (-6.21%) Direct
12/16/2025
10b5-1
12/18/2025
Chief Operating Officer
Officer
Sell
-4,847 @ $76.82
($372,333.45)
141,053 (-3.32%) Direct
12/16/2025
10b5-1
12/18/2025
President, Research and Development
Officer
Sell
-5,447 @ $76.82
($418,423.29)
278,600 (-1.92%) Direct